These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32532530)

  • 1. The utility of intraoperative contrast-enhanced ultrasound in detecting residual disease after focal HIFU for localized prostate cancer.
    Bacchetta F; Martins M; Regusci S; Jichlinski P; Meuwly JY; Lucca I; Valerio M
    Urol Oncol; 2020 Nov; 38(11):846.e1-846.e7. PubMed ID: 32532530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1.
    Apfelbeck M; Clevert DA; Ricke J; Stief C; Schlenker B
    Clin Hemorheol Microcirc; 2018; 69(1-2):93-100. PubMed ID: 29660918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of post-ablation mpMRI as a predictor of residual prostate cancer after focal high intensity focused ultrasound (HIFU) ablation.
    Khandwala YS; Morisetty S; Ghanouni P; Fan RE; Soerensen SJC; Rusu M; Sonn GA
    Urol Oncol; 2022 Nov; 40(11):489.e9-489.e17. PubMed ID: 36058811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up after focal therapy of the prostate with high intensity focused ultrasound (HIFU) using contrast enhanced ultrasound (CEUS) in combination with MRI image fusion.
    Apfelbeck M; Chaloupka M; Schlenker B; Stief CG; Clevert DA
    Clin Hemorheol Microcirc; 2019; 73(1):135-143. PubMed ID: 31561350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncological Outcome and Value of Postoperative Magnetic Resonance Imaging after Focal High-Intensity Focused Ultrasound Therapy for Prostate Cancer.
    Rosenhammer B; Niessen C; Rotzinger L; Reiss J; Schnabel MJ; Burger M; Bründl J
    Urol Int; 2019; 103(3):270-278. PubMed ID: 31466073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association of Tissue Change and Treatment Success During High-intensity Focused Ultrasound Focal Therapy for Prostate Cancer.
    Khandwala YS; Soerensen SJC; Morisetty S; Ghanouni P; Fan RE; Vesal S; Rusu M; Sonn GA
    Eur Urol Focus; 2023 Jul; 9(4):584-591. PubMed ID: 36372735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Systematic Control Biopsies following Partial Gland Ablation with High-Intensity Focused Ultrasound for Clinically Significant Prostate Cancer.
    Rompré-Brodeur A; Marcq G; Tholomier C; Fugaru I; Loutochin O; Anidjar M; Bladou F
    J Urol; 2021 Nov; 206(5):1177-1183. PubMed ID: 34251879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of Multiparametric MRI for Predicting Residual Clinically Significant Prostate Cancer After Focal Laser Ablation.
    Felker ER; Raman SS; Lu DSK; Tuttle M; Margolis DJ; ElKhoury FF; Sayre J; Marks LS
    AJR Am J Roentgenol; 2019 Dec; 213(6):1253-1258. PubMed ID: 31361529
    [No Abstract]   [Full Text] [Related]  

  • 9. MRI-based monitoring of prostate cancer after HIFU: Inter-reader agreement and diagnostic performance of the PI-FAB score.
    Pausch AM; Elsner C; Rupp NJ; Eberli D; Hötker AM
    Eur J Radiol; 2024 Jun; 175():111463. PubMed ID: 38615502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does mpMRI guidance improve HIFU partial gland ablation compared to conventional ultrasound guidance? Early functional outcomes and complications from a single center.
    Sivaraman A; Marra G; Stabile A; Mombet A; Macek P; Lanz C; Cathala N; Moschini M; Carneiro A; Sanchez-Salas R; Cathelineau X
    Int Braz J Urol; 2020; 46(6):984-992. PubMed ID: 32822127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen vs. magnetic resonance imaging parameters for assessing oncological outcomes after high intensity-focused ultrasound focal therapy for localized prostate cancer.
    Dickinson L; Ahmed HU; Hindley RG; McCartan N; Freeman A; Allen C; Emberton M; Kirkham AP
    Urol Oncol; 2017 Jan; 35(1):30.e9-30.e15. PubMed ID: 27663393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can quantitative analysis of multi-parametric MRI independently predict failure of focal salvage HIFU therapy in men with radio-recurrent prostate cancer?
    Rakauskas A; Shah TT; Peters M; Randeva JS; Hosking-Jervis F; Schmainda MJ; Orczyck C; Emberton M; Arya M; Moore C; Ahmed HU
    Urol Oncol; 2021 Dec; 39(12):830.e1-830.e8. PubMed ID: 34049783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy.
    van den Bos W; de Bruin DM; van Randen A; Engelbrecht MR; Postema AW; Muller BG; Varkarakis IM; Skolarikos A; Savci-Heijink CD; Jurhill RR; Zondervan PJ; Laguna Pes MP; Wijkstra H; de Reijke TM; de la Rosette JJ
    Eur Radiol; 2016 Jul; 26(7):2252-60. PubMed ID: 26449559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Exploratory Study of Dose Escalation
    Huber PM; Afzal N; Arya M; Boxler S; Dudderidge T; Emberton M; Guillaumier S; Hindley RG; Hosking-Jervis F; Leemann L; Lewi H; McCartan N; Moore CM; Nigam R; Odgen C; Persad R; Thalmann GN; Virdi J; Winkler M; Ahmed HU
    J Endourol; 2020 Jun; 34(6):641-646. PubMed ID: 32253928
    [No Abstract]   [Full Text] [Related]  

  • 15.
    Burger IA; Müller J; Donati OF; Ferraro DA; Messerli M; Kranzbühler B; Ter Voert EEGW; Muehlematter UJ; Rupp NJ; Mortezavi A; Eberli D
    J Nucl Med; 2019 Aug; 60(8):1118-1123. PubMed ID: 30683764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Whole-Gland High-Intensity Focused Ultrasound vs Whole-Gland High-Intensity Focused Ultrasound for Management of Localized Prostate Cancer: 1-Year Oncological and Functional Outcomes.
    Lei Y; Zanker P; Yildiz S; Hancke K; Seidl D; Koch O; Schwentner C; Mundhenk J
    J Endourol; 2019 Feb; 33(2):100-106. PubMed ID: 30526029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HIFU therapy of localized prostate cancer using image-guided robotic HIFU Focal One].
    Govorov AV; Vasilyev AO; Alaverdyan AI; Kolontarev KB; Pushkar DY
    Urologiia; 2023 May; (2):83-89. PubMed ID: 37401710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging-transrectal ultrasound fusion focal cryotherapy of the prostate: A prospective development study.
    Valerio M; Shah TT; Shah P; Mccartan N; Emberton M; Arya M; Ahmed HU
    Urol Oncol; 2017 Apr; 35(4):150.e1-150.e7. PubMed ID: 27955940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Focal Therapy with Irreversible Electroporation.
    Scheltema MJ; Chang JI; van den Bos W; Böhm M; Delprado W; Gielchinsky I; de Reijke TM; de la Rosette JJ; Siriwardana AR; Shnier R; Stricker PD
    Eur Urol Focus; 2019 Jul; 5(4):585-591. PubMed ID: 29102671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation.
    von Hardenberg J; Westhoff N; Baumunk D; Hausmann D; Martini T; Marx A; Porubsky S; Schostak M; Michel MS; Ritter M
    Urol Oncol; 2018 Sep; 36(9):401.e1-401.e9. PubMed ID: 30093211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.